These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 4287801)
1. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin]. Zduńczyk-Pawelek H Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801 [No Abstract] [Full Text] [Related]
2. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid]. Rudnicka M; Suszko K Med Dosw; 1966; 33():291-302. PubMed ID: 4287506 [No Abstract] [Full Text] [Related]
3. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro]. Mkrtchian SV Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355 [No Abstract] [Full Text] [Related]
4. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro]. Ota Y Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204 [No Abstract] [Full Text] [Related]
5. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis]. Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440 [No Abstract] [Full Text] [Related]
6. [Paper disk methods for determination of the drug sensitivity of Mycobacterium tuberculosis to the 2d order preparations. II]. Afanas'eva IuP; Dorozhkova IR Lab Delo; 1969; 5():296-8. PubMed ID: 4185263 [No Abstract] [Full Text] [Related]
7. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)]. Hayashi S Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047 [No Abstract] [Full Text] [Related]
8. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients]. Kameda K; Kudo S; Iwai K; Ushikubo K Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932 [No Abstract] [Full Text] [Related]
9. Improvement of drg-sensitivity tests on tubercle bacilli. Leat JL; Marks J Tubercle; 1970 Mar; 51(1):68-75. PubMed ID: 4099827 [No Abstract] [Full Text] [Related]
10. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol]. Okamoto K; Watanabe S; Terunuma K Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702 [No Abstract] [Full Text] [Related]
11. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide]. Makeeva OO Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183 [No Abstract] [Full Text] [Related]
12. Experiences of the cycloserine sensitivity tests performed at the second chemotherapy trial of the IUAT. Lind A Scand J Respir Dis Suppl; 1970; 71():279-84. PubMed ID: 4989518 [No Abstract] [Full Text] [Related]
13. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)]. GROSSET J; CANETTI G Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273 [No Abstract] [Full Text] [Related]
14. [PRIMARY RESISTANCE OF TUBERCLE BACILLI TO VIOMYCIN, ETHIONAMIDE, AND CYCLOSERINE]. KOWALCZYK H; RADECKI A; LUKIANSKI M Gruzlica (1926); 1965 Jan; 33():31-4. PubMed ID: 14331696 [No Abstract] [Full Text] [Related]
15. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro]. Janowiec M; Zwolska-Kwiek Z Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778 [No Abstract] [Full Text] [Related]
16. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)]. Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994 [No Abstract] [Full Text] [Related]
17. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order]. Makarevich NM; Rudoĭ NM Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726 [No Abstract] [Full Text] [Related]
18. [On the variability of results of sensitivity determination in tuberculosis bacteria]. Schmiedel A Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009 [No Abstract] [Full Text] [Related]
19. [Studies on thiacetazone resistance of tubercle bacilli. 3. Cross resistance between thiacetazone and ethionamide]. Osato T; Tsukagoshi K; Shimizu H Kekkaku; 1971 Apr; 46(4):89-92. PubMed ID: 4102105 [No Abstract] [Full Text] [Related]
20. [Drug sensitivity of the so-called atypical mycobacteria]. Lucchesi M; Mancini P; Matzeu M Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838 [No Abstract] [Full Text] [Related] [Next] [New Search]